Study Evaluating the Treatment of OTX-TKI for Subjects With Neovascular Age-related Macular Degeneration
Clinical trial NCT04989699 · COMPLETED
Trial details
- NCT number
- NCT04989699
- Sponsor
- Ocular Therapeutix, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-28
- Primary completion
- 2023-02-06
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.